サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1650456

免疫グロブリンの世界市場レポート 2025年

Immunoglobulins Global Market Report 2025

出版日
ページ情報
英文 200 Pages
納期
2～10営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
免疫グロブリンの世界市場レポート 2025年
出版日: 2025年02月04日
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

免疫グロブリンの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR11.4％で315億9,000万米ドルに成長します。予測期間における成長の背景には、先端技術開発のための投資増加、免疫不全治療に対する意識の高まり、免疫不全治療に対する医師の嗜好の高まり、新興市場の増加、スポーツやフィットネスにおける用途の拡大などがあります。予測期間における主な動向としては、ウェアラブルおよびスマート圧迫デバイスの開発、圧迫療法ソリューションのカスタマイズ化、創傷ケア管理における圧迫療法の統合、圧迫療法における患者の快適性とコンプライアンスの重視、患者の転帰を改善するためのメーカーとヘルスケアプロバイダーの連携などが挙げられます。

免疫グロブリン市場の成長は、高齢者人口の増加によって推進されています。この層は特に感染症や自己免疫疾患にかかりやすいです。免疫グロブリン検査は、細菌、ウイルス、アレルギーから身体を守るための抗体を生成する能力を評価するのに役立っています。例えば、2022年10月に世界保健機関（WHO）が発表した報告書によると、2030年までに世界の6人に1人が60歳以上になると予測されています。さらに、2050年には世界の60歳以上の人口は21億人に達すると推定されています。その結果、高齢者人口の増加が予測期間を通じて免疫グロブリン市場の需要を促進すると予測されます。

免疫グロブリン市場の予測成長は、ヘルスケア支出の増加によってさらに支えられます。ヘルスケア支出には、ヘルスケア関連のサービス、治療、薬、医療機器、施設、ヘルスケア管理に対する個人、組織、政府による総支出が含まれます。ヘルスケア分野への投資の増加は、研究開発活動を促進し、先進的な治療法の発見や市場開拓につながる可能性があります。メディケア＆メディケイドサービスセンターが2022年3月に発表した報告書によると、2021年から2030年にかけての国民医療費は年平均5.1％増加し、約6兆8,000億米ドルに達すると推定されています。さらに、メディケアとメディケイドの支出は、同期間にそれぞれ年率7.6％および5.6％増加すると予測されています。その結果、医療支出の増大が免疫グロブリン市場成長の原動力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

  • 世界の免疫グロブリン市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
  • 最終用途産業の分析
  • 世界の免疫グロブリン市場の成長率分析
  • 世界の免疫グロブリン市場の実績：規模と成長、2019～2024年
  • 世界の免疫グロブリン市場の予測：規模と成長、2024～2029年、2034年
  • 世界の免疫グロブリン総アドレス可能市場（TAM）

第6章 市場セグメンテーション

  • 世界の免疫グロブリン市場：製品別、実績と予測、2019～2024年、2024～2029年、2034年
  • IGG
  • IGA
  • IGM
  • IGE
  • IGD
  • 世界の免疫グロブリン市場：投与方法別、実績と予測、2019～2024年、2024～2029年、2034年
  • 静脈内投与法
  • 皮下投与法
  • 世界の免疫グロブリン市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
  • 低ガンマグロブリン血症
  • 慢性炎症性脱髄性多発神経炎（CIDP）
  • 免疫不全疾患
  • 重症筋無力症
  • 特発性血小板減少性紫斑病（ITP）
  • その他の用途
  • 世界の免疫グロブリン市場：IGG（免疫グロブリンG）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • IVIG（免疫グロブリン静注療法）
  • SCIG（皮下免疫グロブリン）
  • 世界の免疫グロブリン市場：IGA（免疫グロブリンA）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • モノクローナルIGA
  • ポリバレントIGA
  • 世界の免疫グロブリン市場：IGM（免疫グロブリンM）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • モノクローナルIGM
  • ポリバレントIGM
  • 世界の免疫グロブリン市場：IGE（免疫グロブリンE）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • アレルゲン特異的IGE
  • モノクローナルIGE
  • 世界の免疫グロブリン市場：IGD（免疫グロブリンD）のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
  • 研究用IGD
  • モノクローナルIGD

第7章 地域別・国別分析

  • 世界の免疫グロブリン市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
  • 世界の免疫グロブリン市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 免疫グロブリン市場：競合情勢
  • 免疫グロブリン市場：企業プロファイル
    • Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
    • Grifols S. A. Overview, Products and Services, Strategy and Financial Analysis
    • Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
    • China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

  • Kedrion SpA
  • LFB SA
  • Biotest AG
  • Sanquin Blood Supply Foundation
  • ADMA Biologics Inc.
  • Option Care Health Inc.
  • Shanghai RAAS Blood Products Co. Ltd.
  • Antibody Solutions
  • Bio Products Laboratory Ltd.
  • Immunovant Inc.
  • Kamada Ltd.
  • Emergent BioSolutions Inc.
  • Fresenius Kabi AG
  • GlaxoSmithKline plc
  • Pfizer Inc.

第32章 世界市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 市場の最近の動向

第35章 市場の潜在力が高い国、セグメント、戦略

  • 免疫グロブリン市場2029年-最も新しい機会を提供する国
  • 免疫グロブリン市場2029年-最も新しい機会を提供するセグメント
  • 免疫グロブリン市場2029年-成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第36章 付録

目次
Product Code: r21630

Immunoglobulins, also known as antibodies, are glycoproteins produced by plasma cells, a type of white blood cell. These molecules play a crucial role in the immune response by selectively identifying and binding to specific antigens, such as viruses or bacteria, contributing to their elimination from the body.

The primary types of immunoglobulins include IgG, IgA, IgM, IgE, and IgD. Immunoglobulin G (IgG) is particularly significant as it is the main stimulator of humoral immunity in extracellular fluids like blood, lymph, and saliva. Each type of immunoglobulin serves a distinct function in the immune system's defense against various pathogens. These immunoglobulins are administered through different modes of delivery, including intravenous and subcutaneous routes. They find applications in treating conditions such as hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), immunodeficiency diseases, myasthenia gravis, idiopathic thrombocytopenic purpura (ITP), and others. The therapeutic use of immunoglobulins helps address deficiencies in the immune system and manage autoimmune disorders, enhancing the body's ability to fight infections and maintain overall health.

The immunoglobulins market research report is one of a series of new reports from The Business Research Company that provides immunoglobulins market statistics, including immunoglobulins industry global market size, regional shares, competitors with a immunoglobulins market share, detailed immunoglobulins market segments, market trends and opportunities, and any further data you may need to thrive in the immunoglobulins industry. This immunoglobulins market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The immunoglobulins market size has grown strongly in recent years. It will grow from $18.85 billion in 2024 to $20.53 billion in 2025 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to increased prevalence of immunodeficiency disorders, growing geriatric population, rising adoption of immunoglobulins in hospitals, favorable government reimbursement plans, increasing prevalence of chronic and autoimmune diseases.

The immunoglobulins market size is expected to see rapid growth in the next few years. It will grow to $31.59 billion in 2029 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing investment for the development of advanced technologies, growing awareness about immunodeficiency therapies, rising preference among physicians for immunodeficiency therapies, increasing number of emerging markets, expansion of applications in sports and fitness. Major trends in the forecast period include development of wearable and smart compression devices, customization of compression therapy solutions, integration of compression therapy in wound care management, emphasis on patient comfort and compliance in compression therapy, collaboration between manufacturers and healthcare providers for improved patient outcomes.

The growth of the immunoglobulins market is being propelled by the increasing geriatric population. This demographic is particularly susceptible to infectious and autoimmune diseases. Immunoglobulin tests are instrumental in assessing the body's ability to generate antibodies for safeguarding against bacteria, viruses, and allergies. For example, a report from the World Health Organization (WHO) in October 2022 revealed that by 2030, one in six individuals globally is projected to be 60 years or older. Additionally, it is estimated that by 2050, the worldwide population of individuals aged 60 or older will reach 2. 1 billion. Consequently, the rising geriatric population is anticipated to drive demand for the immunoglobulins market throughout the forecast period.

The anticipated growth of the immunoglobulins market is further supported by an increase in healthcare expenditure. Healthcare expenditure encompasses the total financial outlay by individuals, organizations, and governments on healthcare-related services, treatments, medications, medical equipment, facilities, and healthcare administration. Elevated investment in the healthcare sector fosters research and development activities in immunoglobulins, potentially leading to the discovery of advanced therapies and augmenting market growth. A report published by the Centers for Medicare & Medicaid Services in March 2022 estimated an average annual increase of 5. 1% in national health spending between 2021 and 2030, reaching nearly $6. 8 trillion. Moreover, Medicare and Medicaid spending is projected to rise at annual rates of 7. 2% and 5. 6%, respectively, during the same period. Consequently, the escalating healthcare expenditure is a driving force behind the growth of the immunoglobulins market.

Major companies in the immunoglobulins market are creating innovative products, such as intravenous immunoglobulins, to cater to larger customer bases, drive sales, and boost revenue. For example, in September 2024, GC Biopharma, a South Korean biotechnology company, launched ALYGLO(TM) (Immune Globulin Intravenous, Human-stwk) 10% Liquid in the U.S. market, aimed at treating primary humoral immunodeficiency (PI) in adults aged 17 and older. This product is now available to patients through specialty pharmacies. The launch is notable as the U.S. is the largest immunoglobulin market globally, valued at around $11.6 billion. GC Biopharma targets $50 million in sales for ALYGLO in its first year, with plans to escalate this to $300 million by 2028. This ambitious growth strategy includes forming partnerships with major U.S. pharmacy benefit managers and specialty pharmacies, which are vital for the effective distribution of immunoglobulin products.

Major companies in the immunoglobulins market are concentrating on strategic partnerships to develop advanced immunoglobulin products. For instance, Biotest, a Germany-based biotechnology company, launched its immunoglobulin product, Yimmugo, in the United States after receiving FDA approval for the treatment of primary immunodeficiencies (PID). This launch is part of a strategic framework established with Kedrion Biopharma for a long-term distribution agreement anticipated to generate over $1 billion in revenue over seven years. The partnership requires Biotest to supply minimum quantities of Yimmugo, with preparations for its market introduction planned for 2025. This collaboration leverages Kedrion's extensive experience in the immunoglobulin market, addressing the needs of around 500,000 PID patients in the U.S. The agreement not only positions Biotest to expand its presence in the growing immunoglobulin market but also improves patient access to essential therapies.

In October 2022, AbbVie Inc., a US-based pharmaceutical company, completed the acquisition of DJS Antibodies Ltd. for an undisclosed amount. This strategic move is expected to enhance AbbVie's existing antibody research efforts, strengthen its immunology portfolio, and establish a significant presence in the bioscience hub of Oxford, UK. The acquisition provides AbbVie with access to the HEPTAD platform, complementing its robust capabilities in biotherapeutics research. Simultaneously, DJS plans to leverage AbbVie's extensive expertise in drug discovery to advance antibody therapeutics and explore novel biological insights, particularly in challenging targets like GPCRs that have proven resistant to biologics-based approaches. DJS Antibodies Ltd. is a UK-based company specializing in antibody therapeutics.

Major companies operating in the immunoglobulins market include Baxter International Inc., CSL Behring LLC, Grifols S. A., Octapharma AG, China Biologic Products Holdings Inc., Kedrion SpA, LFB SA, Biotest AG, Sanquin Blood Supply Foundation, ADMA Biologics Inc., Option Care Health Inc., Shanghai RAAS Blood Products Co. Ltd., Antibody Solutions, Bio Products Laboratory Ltd., Immunovant Inc., Kamada Ltd., Emergent BioSolutions Inc., Fresenius Kabi AG, GlaxoSmithKline plc, Pfizer Inc., Roche Holding AG, Samsung Bioepis Co. Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Zydus Cadila Healthcare Limited

North America was the largest region in the immunoglobulins market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the immunoglobulins market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the immunoglobulins market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The immunoglobins market consists of sales of antibodies, glycoproteins, and antigens. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Immunoglobulins Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on immunoglobulins market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for immunoglobulins ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The immunoglobulins market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: IGG; IGA; IGM; IGE; IGD.
  • 2) By Mode Of Delivery: Intravenous Mode Of Delivery; Subcutaneous Mode Of Delivery
  • 3) By Application: Hypogammaglobulinemia; Chronic Inflammatory demyelinating polyneuropathy (CIDP); Immunodeficiency Disease; Myasthenia Gravis; Idiopathic thrombocytopenic purpura (ITP); Other Applications
  • Subsegments:
  • 1) By IGG (Immunoglobulin G): IVIG (Intravenous Immunoglobulin); SCIG (Subcutaneous Immunoglobulin)
  • 2) By IGA (Immunoglobulin A): Monoclonal IGA; Polyvalent IGA
  • 3) By IGM (Immunoglobulin M): Monoclonal IGM; Polyvalent IGM
  • 4) By IGE (Immunoglobulin E): Allergen-Specific IGE; Monoclonal IGE
  • 5) By IGD (Immunoglobulin D): Research-Use IGD; Monoclonal IGD
  • Companies Mentioned: Baxter International Inc.; CSL Behring LLC; Grifols S. A.; Octapharma AG; China Biologic Products Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Immunoglobulins Market Characteristics

3. Immunoglobulins Market Trends And Strategies

4. Immunoglobulins Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Immunoglobulins Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Immunoglobulins PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Immunoglobulins Market Growth Rate Analysis
  • 5.4. Global Immunoglobulins Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Immunoglobulins Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Immunoglobulins Total Addressable Market (TAM)

6. Immunoglobulins Market Segmentation

  • 6.1. Global Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • IGG
  • IGA
  • IGM
  • IGE
  • IGD
  • 6.2. Global Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Intravenous Mode of Delivery
  • Subcutaneous Mode of Delivery
  • 6.3. Global Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hypogammaglobulinemia
  • Chronic Inflammatory demyelinating polyneuropathy (CIDP)
  • Immunodeficiency Disease
  • Myasthenia Gravis
  • Idiopathic Thrombocytopenic Purpura (ITP)
  • Other Applications
  • 6.4. Global Immunoglobulins Market, Sub-Segmentation Of IGG (Immunoglobulin G), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • IVIG (Intravenous Immunoglobulin)
  • SCIG (Subcutaneous Immunoglobulin)
  • 6.5. Global Immunoglobulins Market, Sub-Segmentation Of IGA (Immunoglobulin A), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal IGA
  • Polyvalent IGA
  • 6.6. Global Immunoglobulins Market, Sub-Segmentation Of IGM (Immunoglobulin M), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monoclonal IGM
  • Polyvalent IGM
  • 6.7. Global Immunoglobulins Market, Sub-Segmentation Of IGE (Immunoglobulin E), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Allergen-Specific IGE
  • Monoclonal IGE
  • 6.8. Global Immunoglobulins Market, Sub-Segmentation Of IGD (Immunoglobulin D), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Research-Use IGD
  • Monoclonal IGD

7. Immunoglobulins Market Regional And Country Analysis

  • 7.1. Global Immunoglobulins Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Immunoglobulins Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Immunoglobulins Market

  • 8.1. Asia-Pacific Immunoglobulins Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Immunoglobulins Market

  • 9.1. China Immunoglobulins Market Overview
  • 9.2. China Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Immunoglobulins Market

  • 10.1. India Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Immunoglobulins Market

  • 11.1. Japan Immunoglobulins Market Overview
  • 11.2. Japan Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Immunoglobulins Market

  • 12.1. Australia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Immunoglobulins Market

  • 13.1. Indonesia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Immunoglobulins Market

  • 14.1. South Korea Immunoglobulins Market Overview
  • 14.2. South Korea Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Immunoglobulins Market

  • 15.1. Western Europe Immunoglobulins Market Overview
  • 15.2. Western Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Immunoglobulins Market

  • 16.1. UK Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Immunoglobulins Market

  • 17.1. Germany Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Immunoglobulins Market

  • 18.1. France Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Immunoglobulins Market

  • 19.1. Italy Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Immunoglobulins Market

  • 20.1. Spain Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Immunoglobulins Market

  • 21.1. Eastern Europe Immunoglobulins Market Overview
  • 21.2. Eastern Europe Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Immunoglobulins Market

  • 22.1. Russia Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Immunoglobulins Market

  • 23.1. North America Immunoglobulins Market Overview
  • 23.2. North America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Immunoglobulins Market

  • 24.1. USA Immunoglobulins Market Overview
  • 24.2. USA Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Immunoglobulins Market

  • 25.1. Canada Immunoglobulins Market Overview
  • 25.2. Canada Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Immunoglobulins Market

  • 26.1. South America Immunoglobulins Market Overview
  • 26.2. South America Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Immunoglobulins Market

  • 27.1. Brazil Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Immunoglobulins Market

  • 28.1. Middle East Immunoglobulins Market Overview
  • 28.2. Middle East Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Immunoglobulins Market

  • 29.1. Africa Immunoglobulins Market Overview
  • 29.2. Africa Immunoglobulins Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Immunoglobulins Market, Segmentation By Mode Of Delivery, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Immunoglobulins Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Immunoglobulins Market Competitive Landscape And Company Profiles

  • 30.1. Immunoglobulins Market Competitive Landscape
  • 30.2. Immunoglobulins Market Company Profiles
    • 30.2.1. Baxter International Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. CSL Behring LLC Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Grifols S. A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Octapharma AG Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. China Biologic Products Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Immunoglobulins Market Other Major And Innovative Companies

  • 31.1. Kedrion SpA
  • 31.2. LFB SA
  • 31.3. Biotest AG
  • 31.4. Sanquin Blood Supply Foundation
  • 31.5. ADMA Biologics Inc.
  • 31.6. Option Care Health Inc.
  • 31.7. Shanghai RAAS Blood Products Co. Ltd.
  • 31.8. Antibody Solutions
  • 31.9. Bio Products Laboratory Ltd.
  • 31.10. Immunovant Inc.
  • 31.11. Kamada Ltd.
  • 31.12. Emergent BioSolutions Inc.
  • 31.13. Fresenius Kabi AG
  • 31.14. GlaxoSmithKline plc
  • 31.15. Pfizer Inc.

32. Global Immunoglobulins Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Immunoglobulins Market

34. Recent Developments In The Immunoglobulins Market

35. Immunoglobulins Market High Potential Countries, Segments and Strategies

  • 35.1 Immunoglobulins Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Immunoglobulins Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Immunoglobulins Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer